First phase 3 test of coronavirus vaccine candidate begins in US | TheHill

First phase 3 test of coronavirus vaccine candidate begins in US | TheHill: An investigational vaccine developed by drugmaker Moderna and the National Institute of Allergy and Infectious Diseases began phase three trials on Monday, becoming the first U.S. candidate to reach that step in testing.